784 related articles for article (PubMed ID: 16432373)
1. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Voudouri T; Kouroumalis EA
Inflamm Bowel Dis; 2006 Feb; 12(2):100-5. PubMed ID: 16432373
[TBL] [Abstract][Full Text] [Related]
2. Serum adipokines in inflammatory bowel disease.
Waluga M; Hartleb M; Boryczka G; Kukla M; Zwirska-Korczala K
World J Gastroenterol; 2014 Jun; 20(22):6912-7. PubMed ID: 24944482
[TBL] [Abstract][Full Text] [Related]
3. The effect of infliximab on circulating levels of leptin, adiponectin and resistin in patients with inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Xidakis C; Polychronaki M; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):789-94. PubMed ID: 17700265
[TBL] [Abstract][Full Text] [Related]
4. Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease.
Kapsoritakis AN; Kapsoritaki AI; Davidi IP; Lotis VD; Manolakis AC; Mylonis PI; Theodoridou AT; Germenis AE; Potamianos SP
BMC Gastroenterol; 2008 Nov; 8():55. PubMed ID: 19036126
[TBL] [Abstract][Full Text] [Related]
5. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease.
Valentini L; Wirth EK; Schweizer U; Hengstermann S; Schaper L; Koernicke T; Dietz E; Norman K; Buning C; Winklhofer-Roob BM; Lochs H; Ockenga J
Nutrition; 2009 Feb; 25(2):172-81. PubMed ID: 18849144
[TBL] [Abstract][Full Text] [Related]
6. Leptin, adiponectin, resistin, and ghrelin--implications for inflammatory bowel disease.
Karmiris K; Koutroubakis IE; Kouroumalis EA
Mol Nutr Food Res; 2008 Aug; 52(8):855-66. PubMed ID: 18383234
[TBL] [Abstract][Full Text] [Related]
7. Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease.
Koutroubakis IE; Malliaraki N; Dimoulios PD; Karmiris K; Castanas E; Kouroumalis EA
Dig Dis Sci; 2004 Sep; 49(9):1433-7. PubMed ID: 15481315
[TBL] [Abstract][Full Text] [Related]
8. Serum ST2 in inflammatory bowel disease: a potential biomarker for disease activity.
Boga S; Alkim H; Koksal AR; Ozagari AA; Bayram M; Tekin Neijmann S; Sen I; Alkim C
J Investig Med; 2016 Jun; 64(5):1016-24. PubMed ID: 27001944
[TBL] [Abstract][Full Text] [Related]
9. Hyperadiponectinemia During Infliximab Induction Therapy in Pediatric Crohn Disease.
Frivolt K; Schwerd T; Schatz SB; Freudenberg F; Prell C; Werkstetter KJ; Bufler P; Koletzko S
J Pediatr Gastroenterol Nutr; 2018 Jun; 66(6):915-919. PubMed ID: 29287006
[TBL] [Abstract][Full Text] [Related]
10. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
[TBL] [Abstract][Full Text] [Related]
11. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men.
Oh KW; Lee WY; Rhee EJ; Baek KH; Yoon KH; Kang MI; Yun EJ; Park CY; Ihm SH; Choi MG; Yoo HJ; Park SW
Clin Endocrinol (Oxf); 2005 Aug; 63(2):131-8. PubMed ID: 16060905
[TBL] [Abstract][Full Text] [Related]
12. Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases.
Nikolaus S; Schulte B; Al-Massad N; Thieme F; Schulte DM; Bethge J; Rehman A; Tran F; Aden K; Häsler R; Moll N; Schütze G; Schwarz MJ; Waetzig GH; Rosenstiel P; Krawczak M; Szymczak S; Schreiber S
Gastroenterology; 2017 Dec; 153(6):1504-1516.e2. PubMed ID: 28827067
[TBL] [Abstract][Full Text] [Related]
13. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease.
Weigert J; Obermeier F; Neumeier M; Wanninger J; Filarsky M; Bauer S; Aslanidis C; Rogler G; Ott C; Schäffler A; Schölmerich J; Buechler C
Inflamm Bowel Dis; 2010 Apr; 16(4):630-7. PubMed ID: 19714754
[TBL] [Abstract][Full Text] [Related]
14. Obestatin/ghrelin ratio: a new activity index in inflammatory bowel diseases.
Alexandridis E; Zisimopoulos A; Liratzopoulos N; Katsos I; Manolas K; Kouklakis G
Inflamm Bowel Dis; 2009 Oct; 15(10):1557-61. PubMed ID: 19408254
[TBL] [Abstract][Full Text] [Related]
15. Circulating leptin and adiponectin and their relation to glucose metabolism in children with Crohn's disease and ulcerative colitis.
Chouliaras G; Panayotou I; Margoni D; Mantzou E; Pervanidou P; Manios Y; Chrousos GP; Roma E
Pediatr Res; 2013 Oct; 74(4):420-6. PubMed ID: 23823177
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin, leptin, and resistin in patients with aortic stenosis without concomitant atherosclerotic vascular disease.
Kolasa-Trela R; Miszalski-Jamka T; Grudzień G; Wypasek E; Kostkiewicz M
Pol Arch Med Wewn; 2011 Oct; 121(10):352-59. PubMed ID: 21952524
[TBL] [Abstract][Full Text] [Related]
17. Relationship between neutrophil gelatinase-associated lipocalin (NGAL) levels and inflammatory bowel disease type and activity.
Yeşil A; Gönen C; Senateş E; Paker N; Gökden Y; Koçhan K; Erdem ED; Gündüz F
Dig Dis Sci; 2013 Sep; 58(9):2587-93. PubMed ID: 23633156
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Serum Calprotectin Levels in Patients with Inflammatory Bowel Disease.
Mori A; Mitsuyama K; Sakemi R; Yoshioka S; Fukunaga S; Kuwaki K; Yamauchi R; Araki T; Yoshimura T; Yamasaki H; Tsuruta K; Morita T; Yamasaki S; Tsuruta O; Torimura T
Kurume Med J; 2021 Dec; 66(4):209-215. PubMed ID: 34690210
[TBL] [Abstract][Full Text] [Related]
19. Decreased serum fetuin-A levels and active inflammatory bowel disease.
Ma P; Feng YC
Am J Med Sci; 2014 Jul; 348(1):47-51. PubMed ID: 24487480
[TBL] [Abstract][Full Text] [Related]
20. Serum Interleukin-33 level in Saudi children with inflammatory bowel disease.
Saadah OI; Al-Harthi SE; Al-Mughales JA; Bin-Taleb YY; Baeshen RS
Int J Clin Exp Pathol; 2015; 8(12):16000-6. PubMed ID: 26884875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]